Canada Foundation for Innovation invests $ 2.2M to support uOttawa researchers

Posted on Wednesday, April 11, 2018

Researcher

University of Ottawa researchers have received a $2.2 million boost from the Government of Canada to help fund the specialized tools and laboratories that are needed to break new ground in areas such as cancer therapies, wastewater treatment, stroke recovery, and fake news, to keep Canada at the forefront of innovation.

The Honourable Kirsty Duncan, Minister of Science and Minister of Sport and Persons with Disabilities, announced the funding, which will be directed through the Canada Foundation for Innovation’s John R. Evans Leaders Fund.

The John R. Evans Leaders Fund helps a select number of exceptional researchers at institutions across the country to conduct leading-edge research by giving them the tools and equipment they need to be or become leaders in their field.

The eight uOttawa research projects include:

Creating novel therapies for bronchopulmonary dysplasia
Robert Jankov, Faculty of Medicine, aims to save lives by developing new treatments using computer-assisted stereology to assist children affected by Bronchopulmonary dysplasia (BPD).

Using cold climate agri-food to study wastewater
Christopher Kinsley, Faculty of Engineering, looks to combat water quality issues by developing low-cost, low-energy wastewater treatment technologies to remove and recover nutrients.

Looking at neurohealth and rehabilitation
Lara Pilutti, Faculty of Health Sciences, studies neurorehabilitation and aims to develop effective exercises to help improve quality of life for patients affected by neurological conditions such as multiple sclerosis, Alzheimer's disease, and spinal cord injuries.  

Computer screen showing lab results

Linked Culture Lab
Constance Crompton, Faculty of Arts, focuses on creating a world-class digital humanities research facility to combat “fake news” and "alternative facts” to provide a comprehensive understanding of past trends and events to ensure informed future action.

Understanding the role of Dipeptidyl Peptidase 4 in Type 2 Diabetes and Cardiovascular Disease
Erin Mulvihill, Faculty of Medicine, aims to create new combination treatments to combat Type 2 Diabetes by leveraging what normally occurs in our bodies.

Enhancing outcome of individuals impacted by stroke
Gergely Silasi, Faculty of Medicine, looks to identify how remaining brain regions can reorganize in order to take over some of the lost functions after one suffers a stroke.

Creating next-generation optical imaging instruments and techniques
Albert Stolow, Faculty of Science, will result in building Canada's first and only advanced Stimulated Raman Microscopy lab to provide ultrafast nonlinear optical microscopy and lead the world in next-generation label-free, chemical-specific optical imaging.

Developing potential cancer metabolic therapies
Julie St-Pierre, Faculty of Medicine, aims to identify the metabolic networks that drive the progression of poor outcome cancers in order to develop new ways to treat these with novel cancer therapies.

 

Media inquiries:

Véronique Vallée
Media Relations Officer
Cell: 613-863-7221 
veronique.vallee@uOttawa.ca

Back to top